EpiPen Trial Not Feasible Nor Prudent Amid Virus, Judge Says
A Kansas federal judge on Wednesday postponed an April trial date for Pfizer and Mylan to face consumer class claims in multidistrict litigation alleging they illegally inflated EpiPen prices, finding it...To view the full article, register now.
Already a subscriber? Click here to view full article